查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600476

分子診斷自動化市場：按類型、自動化類型、產品、應用和最終用途 - 全球預測 2025-2030

Automation in the Molecular Diagnostics Market by Type (Amplification Automation, Analysis Automation, Extraction Automation), Automation Type (Modular Automation, Total Lab Automation), Product, Application, End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年分子診斷自動化市場價值為117.5億美元，預計到2024年將達到135.4億美元，複合年成長率為15.79%，預計到2030年將達到328.1億美元。

分子診斷自動化是指先進技術和自動化系統的整合，以簡化和增強用於各種醫學研究目的的分子檢測和分析過程。該領域對自動化的需求是由更高的精度、更少的錯誤、更快的處理時間和更高的吞吐量的需求所驅動的。自動化的應用涵蓋樣品製備、測定開發、資料分析和結果解釋，為實驗室、醫院和研究機構帶來顯著的好處。最終用途範圍廣泛，涵蓋臨床診斷、藥物發現、個人化醫療和流行病學。

主要市場統計
基準年[2023] 117.5億美元
預測年份 [2024] 135.4億美元
預測年份 [2030] 328.1億美元
複合年成長率（%） 15.79%

根據市場洞察，關鍵的成長要素包括慢性病盛行率上升、對個人化醫療的需求不斷增加以及診斷設備的技術進步。此外，人工智慧和機器學習的整合提供了新的商機，並有望徹底改變診斷過程中的資料解釋和業務效率。公司可以透過投資人工智慧主導平台的研發並建立策略夥伴關係關係來抓住這些機會，以增強其專業知識和市場覆蓋範圍。

然而，市場面臨實施成本高、監管障礙以及資料隱私和管理方面的道德問題等限制。應對這些挑戰需要開發具有成本效益的解決方案和強大的網路安全措施，並建立明確的法律規範以確保合規性。

創新部分包括開發就地檢驗解決方案、改進的生物感測器以及有望分散和加速診斷服務的實驗室晶片技術。奈米技術和生物資訊學的研究也描述了診斷測試靈敏度和特異性突破性改進的途徑。該市場的動態和競爭性質需要不斷保持警惕並適應新趨勢和技術，以保持該細分市場的成長和相關性。

市場動態：針對分子診斷市場快速發展的自動化揭示的關鍵市場洞察

分子診斷的自動化市場正在因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 全球慢性病盛行率不斷上升
    • 分子診斷對精確度和速度的需求
    • 個人化醫療和精準醫療日益受到關注
  • 市場限制因素
    • 與自動化技術相關的高初始投資
  • 市場機會
    • 活性化技術提供者和分子診斷公司之間的合作
    • 衛生基礎設施和研究方面的政府計畫和資金
  • 市場問題
    • 核准流程嚴格規定

波特五力：分子診斷自動化市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解分子診斷市場自動化的外部影響

外部宏觀環境因素在塑造分子診斷自動化市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解分子診斷自動化市場的競爭格局

對分子診斷自動化市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：分子診斷市場自動化供應商的績效評估

FPNV 定位矩陣是評估分子診斷自動化市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製分子診斷市場自動化的成功之路

對於旨在加強在全球市場的影響力的公司來說，對分子診斷自動化市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地慢性病發生率上升
      • 分子診斷對準確性和速度的需求
      • 日益關注個人化醫療和精準醫療
    • 抑制因素
      • 與自動化技術相關的高初始投資
    • 機會
      • 技術提供者和分子診斷公司之間的合作活動增加
      • 衛生基礎設施和研究方面的政府計畫和資金
    • 任務
      • 嚴格的核准流程規定
  • 市場區隔分析
    • 類型：擴增自動化在高通量環境中的重要性日益增加
    • 自動化類型：透過全面的實驗室自動化和模組化解決方案來提高分子診斷效率
    • 產品：自動化創新以及與分子診斷軟體和儀器的整合
    • 應用：自動化提高了癌症、感染疾病、基因檢測和血液檢測的準確性
    • 最終用途：研究機構更喜歡高度可自訂和可擴展的自動化解決方案
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章分子診斷自動化市場：按類型

  • 介紹
  • 擴增自動化
  • 分析自動化
  • 萃取自動化
  • 後分析自動化
  • 分析前自動化

第7章分子診斷自動化市場：依自動化類型

  • 介紹
  • 模組化自動化
  • 實驗室全面自動化

第8章分子診斷自動化市場：依產品

  • 介紹
  • 裝置
  • 服務
  • 軟體

第9章分子診斷自動化市場：依應用分類

  • 介紹
  • 驗血
  • 基因檢測
  • 感染疾病
  • 腫瘤學

第 10 章分子診斷自動化市場：依最終用途分類

  • 介紹
  • 臨床實驗室
  • 醫院
  • 研究所

第11章美洲分子診斷自動化市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區分子診斷自動化市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲分子診斷自動化市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Biocare Medical 和 Molecular Instruments 合作改進成像技術
    • 羅氏診斷與日立高新技術延續 46 年合作關係，徹底改變分子診斷自動化
    • 布魯克公司以 8.7 億歐元收購 ELITechGroup 以增強診斷能力
    • Devyser Diagnostics 和 Hamilton 合作自動化並增強基因檢測工作流程
    • 博世醫療保健和 Randox 投資 1.59 億美元開發 Vivalytic 分子診斷平台
    • HORIBA Medical 宣布推出 HELO 2.0，推進自動化血液學測試，已獲得 CE-IVDR核准並等待 FDA等候核准
    • 推出 LuminUltra 的 BugCount Guardian 以增強工業微生物監測
    • Yourgene Health 宣布創新 MagBench 技術以增強非侵入性產前檢測
    • Menarini Diagnostics 推出 PRIME MDx 平台，徹底改變自動化分子診斷
    • Mylab Discovery Solutions 和 AstraGene LLC 合作推動阿拉伯聯合大公國和科威特的自動化分子診斷
  • 戰略分析和建議
    • F. Hoffmann-La Roche Ltd.
    • Meridian Bioscience, Inc.
    • Revvity, Inc.
    • Seegene Inc.

公司名單

  • Abbott Laboratories
  • Adaltis Srl
  • Agilent Technologies, Inc.
  • altona Diagnostics GmbH
  • Aurora Biomed Inc.
  • Becton, Dickinson and Company
  • Biocartis NV
  • bioMerieux SA
  • Bruker Corporation
  • Danaher Corporation
  • DiaSorin SpA
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd.
  • Festo Corporation
  • Hamilton Company
  • Hologic, Inc.
  • Hudson Robotics, Inc.
  • LabVantage Solutions Inc.
  • MEGAROBO technologies Co., Ltd.
  • Meridian Bioscience, Inc.
  • Molgen BV
  • Mylab Discovery Solutions Pvt. Ltd.
  • QIAGEN NV
  • QuidelOrtho Corporation
  • Revvity, Inc.
  • Sansure BIoTech Inc.
  • Scispot.io Inc.
  • Seegene Inc.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.
  • Vela Diagnostics Holding Pte Ltd.
  • Waters Corporation
Product Code: MRR-2D1F5C65740B

The Automation in the Molecular Diagnostics Market was valued at USD 11.75 billion in 2023, expected to reach USD 13.54 billion in 2024, and is projected to grow at a CAGR of 15.79%, to USD 32.81 billion by 2030.

Automation in molecular diagnostics refers to the integration of advanced technologies and automated systems to streamline and enhance the processes involved in the detection and analysis of molecules for various medical and research purposes. The necessity for automation in this field is driven by the need for higher precision, reduced errors, faster processing time, and increased throughput, which are crucial for responding effectively to the growing demand for diagnostic tests. Applications of automation span across sample preparation, assay development, data analysis, and result interpretation, significantly benefiting laboratories, hospitals, and research institutions. The end-use scope is expansive, catering to clinical diagnostics, drug discovery, personalized medicine, and epidemiology.

KEY MARKET STATISTICS
Base Year [2023] USD 11.75 billion
Estimated Year [2024] USD 13.54 billion
Forecast Year [2030] USD 32.81 billion
CAGR (%) 15.79%

Market insights reveal that key growth factors include the rising prevalence of chronic diseases, increased demand for personalized medicine, and technological advancements in diagnostic equipment. Furthermore, emerging opportunities are presented by the integration of artificial intelligence and machine learning, which promise to revolutionize data interpretation and operational efficiency in diagnostic processes. Companies can capture these opportunities by investing in Research & Development for AI-driven platforms and by forming strategic partnerships to enhance expertise and market reach.

However, the market faces limitations such as high cost of implementation, regulatory hurdles, and ethical concerns surrounding data privacy and management. Addressing these challenges requires developing cost-effective solutions and robust cybersecurity measures, as well as a clear regulatory framework to ensure compliance.

Innovation areas ripe for exploration include the development of point-of-care testing solutions, improved biosensors, and lab-on-a-chip technologies that promise to decentralize and expedite diagnostic services. Research in nanotechnology and bioinformatics can also provide avenues for breakthrough improvements in sensitivity and specificity of diagnostic tests. The nature of this market is dynamic and competitive, necessitating constant vigilance and adaptability to new trends and technologies to sustain growth and relevance in the field.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Automation in the Molecular Diagnostics Market

The Automation in the Molecular Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of chronic diseases across the globe
    • Need for accuracy and speed in molecular diagnostics
    • Rising focus on personalized healthcare and precision medicine
  • Market Restraints
    • High initial investment associated with automation technology
  • Market Opportunities
    • Rising collaborative activities among technology providers and molecular diagnostics companies
    • Government programs and funding in healthcare infrastructure and research
  • Market Challenges
    • Stringent regulations associated with the approval process

Porter's Five Forces: A Strategic Tool for Navigating the Automation in the Molecular Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Automation in the Molecular Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Automation in the Molecular Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Automation in the Molecular Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Automation in the Molecular Diagnostics Market

A detailed market share analysis in the Automation in the Molecular Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Automation in the Molecular Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Automation in the Molecular Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Automation in the Molecular Diagnostics Market

A strategic analysis of the Automation in the Molecular Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Automation in the Molecular Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adaltis S.r.l., Agilent Technologies, Inc., altona Diagnostics GmbH, Aurora Biomed Inc., Becton, Dickinson and Company, Biocartis NV, bioMerieux SA, Bruker Corporation, Danaher Corporation, DiaSorin S.p.A., Eppendorf SE, F. Hoffmann-La Roche Ltd., Festo Corporation, Hamilton Company, Hologic, Inc., Hudson Robotics, Inc., LabVantage Solutions Inc., MEGAROBO technologies Co., Ltd., Meridian Bioscience, Inc., Molgen B.V., Mylab Discovery Solutions Pvt. Ltd., QIAGEN N.V., QuidelOrtho Corporation, Revvity, Inc., Sansure Biotech Inc., Scispot.io Inc., Seegene Inc., Siemens Healthineers AG, Sysmex Corporation, Tecan Group Ltd., Thermo Fisher Scientific Inc., Vela Diagnostics Holding Pte Ltd., and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Automation in the Molecular Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Amplification Automation, Analysis Automation, Extraction Automation, Post-analytical Automation, and Pre-analytical Automation.
  • Based on Automation Type, market is studied across Modular Automation and Total Lab Automation.
  • Based on Product, market is studied across Equipment, Services, and Software.
  • Based on Application, market is studied across Blood Screening, Genetic Testing, Infectious Diseases, and Oncology.
  • Based on End-use, market is studied across Clinical Laboratories, Hospitals, and Research Institutions.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of chronic diseases across the globe
      • 5.1.1.2. Need for accuracy and speed in molecular diagnostics
      • 5.1.1.3. Rising focus on personalized healthcare and precision medicine
    • 5.1.2. Restraints
      • 5.1.2.1. High initial investment associated with automation technology
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising collaborative activities among technology providers and molecular diagnostics companies
      • 5.1.3.2. Government programs and funding in healthcare infrastructure and research
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations associated with the approval process
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing significance of amplification automation in high-throughput settings
    • 5.2.2. Automation Type: Enhancing efficiency in molecular diagnostics with total lab automation and modular solutions
    • 5.2.3. Product: Revolutionizing and integrating the automation into the software and equipment of molecular diagnostics
    • 5.2.4. Application: Automation enhances precision in cancer, infectious disease, genetic testing, and blood screening
    • 5.2.5. End-use: Research institutions prefer highly customizable and scalable automation solutions
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Automation in the Molecular Diagnostics Market, by Type

  • 6.1. Introduction
  • 6.2. Amplification Automation
  • 6.3. Analysis Automation
  • 6.4. Extraction Automation
  • 6.5. Post-analytical Automation
  • 6.6. Pre-analytical Automation

7. Automation in the Molecular Diagnostics Market, by Automation Type

  • 7.1. Introduction
  • 7.2. Modular Automation
  • 7.3. Total Lab Automation

8. Automation in the Molecular Diagnostics Market, by Product

  • 8.1. Introduction
  • 8.2. Equipment
  • 8.3. Services
  • 8.4. Software

9. Automation in the Molecular Diagnostics Market, by Application

  • 9.1. Introduction
  • 9.2. Blood Screening
  • 9.3. Genetic Testing
  • 9.4. Infectious Diseases
  • 9.5. Oncology

10. Automation in the Molecular Diagnostics Market, by End-use

  • 10.1. Introduction
  • 10.2. Clinical Laboratories
  • 10.3. Hospitals
  • 10.4. Research Institutions

11. Americas Automation in the Molecular Diagnostics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Automation in the Molecular Diagnostics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Automation in the Molecular Diagnostics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Biocare Medical and Molecular Instruments Join Forces to Elevate Bioimaging Technologies
    • 14.3.2. Roche Diagnostics and Hitachi High-Tech Extend 46-Year Partnership to Innovate Molecular Diagnostic Automation
    • 14.3.3. Bruker Corporation Acquires ELITechGroup for EUR 870 million to Boost Diagnostic Capabilities
    • 14.3.4. Devyser Diagnostics and Hamilton Partner to Automate and Enhance Genetic Testing Workflows
    • 14.3.5. Bosch Healthcare and Randox Invest USD 159 Million to Advance Vivalytic Molecular Diagnostics Platform
    • 14.3.6. HORIBA Medical Unveils HELO 2.0, Advancing Automated Hematology with CE-IVDR Approval and Awaiting FDA Nod
    • 14.3.7. The Launch of BugCount Guardian by LuminUltra to Enhnace Industrial Microbial Monitoring
    • 14.3.8. Yourgene Health Unveils Revolutionary MagBench Technology for Enhanced Non-Invasive Prenatal Testing
    • 14.3.9. Menarini Diagnostics Launches PRIME MDx Platform, Revolutionizing Automated Molecular Diagnostics
    • 14.3.10. Mylab Discovery Solutions and AstraGene LLC Form Partnership to Advance Automated Molecular Diagnostics in UAE and Kuwait
  • 14.4. Strategy Analysis & Recommendation
    • 14.4.1. F. Hoffmann-La Roche Ltd.
    • 14.4.2. Meridian Bioscience, Inc.
    • 14.4.3. Revvity, Inc.
    • 14.4.4. Seegene Inc.

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Adaltis S.r.l.
  • 3. Agilent Technologies, Inc.
  • 4. altona Diagnostics GmbH
  • 5. Aurora Biomed Inc.
  • 6. Becton, Dickinson and Company
  • 7. Biocartis NV
  • 8. bioMerieux SA
  • 9. Bruker Corporation
  • 10. Danaher Corporation
  • 11. DiaSorin S.p.A.
  • 12. Eppendorf SE
  • 13. F. Hoffmann-La Roche Ltd.
  • 14. Festo Corporation
  • 15. Hamilton Company
  • 16. Hologic, Inc.
  • 17. Hudson Robotics, Inc.
  • 18. LabVantage Solutions Inc.
  • 19. MEGAROBO technologies Co., Ltd.
  • 20. Meridian Bioscience, Inc.
  • 21. Molgen B.V.
  • 22. Mylab Discovery Solutions Pvt. Ltd.
  • 23. QIAGEN N.V.
  • 24. QuidelOrtho Corporation
  • 25. Revvity, Inc.
  • 26. Sansure Biotech Inc.
  • 27. Scispot.io Inc.
  • 28. Seegene Inc.
  • 29. Siemens Healthineers AG
  • 30. Sysmex Corporation
  • 31. Tecan Group Ltd.
  • 32. Thermo Fisher Scientific Inc.
  • 33. Vela Diagnostics Holding Pte Ltd.
  • 34. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION AUTOMATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ANALYSIS AUTOMATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY EXTRACTION AUTOMATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY POST-ANALYTICAL AUTOMATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRE-ANALYTICAL AUTOMATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY MODULAR AUTOMATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TOTAL LAB AUTOMATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AUTOMATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 238. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023